Abstract
A new thirteen amino acid peptide, named low molecular weight protamine (LMWP), was obtained through the enzymatic digestion of native protamine. Both in vitro and in vivo results showed that LMWP fully maintained the heparin neutralization function of protamine but had much lower immunogenicity and antigenicity. Unlike protamine, neither LMWP nor LMWP/heparin complexes caused significant blood platelet aggregation in rats. These results suggest that LMWP can be used as a substitute for protamine for developing a new generation of nontoxic heparin antagonists.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Metz, S., and Horrow, J. C. (1994) in Pharmacology and Physiology in Anesthetic Practice (Stoelting, R. K., ed.) Vol. 1, J. B. Lippincott, Philadelphia, pp. 1-15.
Weiler, J. M., Gelhaus, M. A., Carter, J. G., Meng, R. L., Benson, P. M., Hottel, R. A., Schillig, K. B., Vegh, A. B., and Clark, W. R. (1985) J. Allergy Clin. Immunol., 75, 297-303.
Horrow, J. C. (1985) Anesth. Analg., 64, 348-361.
Lindblad, B. (1989) Eur. J. Vasc. Surg., 3, 195-201.
Rent, R., Ertel, N., Eisenstein, R., and Gewurz, H. (1975) J. Immunol., 114, 120-124.
Okajima, Y., Kanayama, S., Maeda, Y., Urano, S., Kitani, T., Watada, M., Nakagawa, N., and Ijichi, H. (1981) Thromb. Res., 24, 21-29.
Rosenberg, R. (1987) in Hemostasis and Thrombosis: Basic Principles and Clinical Practice (Colman, R. W., Marder, V. J., and Hirsh, J., eds.) 2nd Ed., J. B. Lippincott, Philadelphia, pp. 1373-1392.
Sela, M. (1969) Science, 166, 1365-1374.
Cooper, H. N., and Paterson, Y. (1991) in Current Protocols in Immunology (Coligan, J. E., Kruisbbek, A. M., and Margulies, D. H., eds.) Green Publishing Associates and Wiley-Interscience, New York, pp. 2.4.1-2.4.7.
Hulin, M. S., Wakefield, T. W., Andrews, P. C., Wrobleski, S. K., Kadell, A. M., Downing, L. J., and Stanley, J. C. (1997) Lab. Anim. Sci., 47, 153-160.
Nell, L. J., and Thomas, J. W. (1988) Diabetes, 37, 172-176.
Schick, B. P., Gradowski, J. F., San Antonio, J. D., and Martinez, J. (2001) Thromb. Haemost., 85, 482-487.
Shenoy, S., Harris, R. B., and Sobel, M. (1995) Curr. Pharm. Res., 5, 965-986.
Hulin, M. S., Wakefield, T. W., Andrews, P. C., Wrobleski, S. K., Stoneham, M. D., Doyle, A. R., Zelenock, G. B., Jacobs, L. A., Shanley, C. J., TenCate, V. M., and Stanley, J. C. (1997) J. Vasc. Surg., 26, 1043-1048.
Levy, J. H., Cormack, J. G., and Morales, A. (1995) Anesth. Analg., 81, 35-37.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liang, J.F., Zhen, L., Chang, LC. et al. A Less Toxic Heparin Antagonist—Low Molecular Weight Protamine. Biochemistry (Moscow) 68, 116–120 (2003). https://doi.org/10.1023/A:1022109905487
Issue Date:
DOI: https://doi.org/10.1023/A:1022109905487